These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 28105008)

  • 21. Strain and sex based characterization of behavioral expressions in non-induced compulsive-like mice.
    Mitra S; Bastos CP; Chesworth S; Frye C; Bult-Ito A
    Physiol Behav; 2017 Jan; 168():103-111. PubMed ID: 27838311
    [TBL] [Abstract][Full Text] [Related]  

  • 22. α4β2 neuronal nicotinic receptor positive allosteric modulation: an approach for improving the therapeutic index of α4β2 nAChR agonists in pain.
    Lee CH; Zhu C; Malysz J; Campbell T; Shaughnessy T; Honore P; Polakowski J; Gopalakrishnan M
    Biochem Pharmacol; 2011 Oct; 82(8):959-66. PubMed ID: 21763685
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Levamisole: A Positive Allosteric Modulator for the α3β4 Nicotinic Acetylcholine Receptors Prevents Weight Gain in the CD-1 Mice on a High Fat Diet.
    Lewis JA; Yakel JL; Pandya AA
    Curr Pharm Des; 2017; 23(12):1869-1872. PubMed ID: 27908269
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Of mice and marbles: Novel perspectives on burying behavior as a screening test for psychiatric illness.
    Wolmarans de W; Stein DJ; Harvey BH
    Cogn Affect Behav Neurosci; 2016 Jun; 16(3):551-60. PubMed ID: 26920212
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Desformylflustrabromine: A Novel Positive Allosteric Modulator for beta2 Subunit Containing Nicotinic Receptor Sub-Types.
    Pandya AA
    Curr Pharm Des; 2016; 22(14):2057-63. PubMed ID: 26818864
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potentiation of analgesic efficacy but not side effects: co-administration of an α4β2 neuronal nicotinic acetylcholine receptor agonist and its positive allosteric modulator in experimental models of pain in rats.
    Zhu CZ; Chin CL; Rustay NR; Zhong C; Mikusa J; Chandran P; Salyers A; Gomez E; Simler G; Lewis LG; Gauvin D; Baker S; Pai M; Tovcimak A; Brown J; Komater V; Fox GB; Decker MW; Jacobson PB; Gopalakrishnan M; Lee CH; Honore P
    Biochem Pharmacol; 2011 Oct; 82(8):967-76. PubMed ID: 21620806
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of nicotine on quinpirole-induced checking behavior in rats: implications for obsessive-compulsive disorder.
    Tizabi Y; Louis VA; Taylor CT; Waxman D; Culver KE; Szechtman H
    Biol Psychiatry; 2002 Jan; 51(2):164-71. PubMed ID: 11822995
    [TBL] [Abstract][Full Text] [Related]  

  • 28. α4β2* neuronal nicotinic receptor ligands (agonist, partial agonist and positive allosteric modulators) as therapeutic prospects for pain.
    Nirogi R; Goura V; Abraham R; Jayarajan P
    Eur J Pharmacol; 2013 Jul; 712(1-3):22-9. PubMed ID: 23660369
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LY2087101 and dFBr share transmembrane binding sites in the (α4)3(β2)2 Nicotinic Acetylcholine Receptor.
    Deba F; Ali HI; Tairu A; Ramos K; Ali J; Hamouda AK
    Sci Rep; 2018 Jan; 8(1):1249. PubMed ID: 29352227
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analgesic effects mediated by neuronal nicotinic acetylcholine receptor agonists: correlation with desensitization of α4β2* receptors.
    Zhang J; Xiao YD; Jordan KG; Hammond PS; Van Dyke KM; Mazurov AA; Speake JD; Lippiello PM; James JW; Letchworth SR; Bencherif M; Hauser TA
    Eur J Pharm Sci; 2012 Dec; 47(5):813-23. PubMed ID: 23036283
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Positive allosteric modulation of α4β2 nAChR agonist induced behaviour.
    Rode F; Munro G; Holst D; Nielsen EØ; Troelsen KB; Timmermann DB; Rønn LC; Grunnet M
    Brain Res; 2012 Jun; 1458():67-75. PubMed ID: 22552114
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stimulation of dopamine release by nicotinic acetylcholine receptor ligands in rat brain slices correlates with the profile of high, but not low, sensitivity alpha4beta2 subunit combination.
    Anderson DJ; Malysz J; Grønlien JH; El Kouhen R; Håkerud M; Wetterstrand C; Briggs CA; Gopalakrishnan M
    Biochem Pharmacol; 2009 Oct; 78(7):844-51. PubMed ID: 19555668
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting α4β2 nicotinic acetylcholine receptors in central nervous system disorders: perspectives on positive allosteric modulation as a therapeutic approach.
    Grupe M; Grunnet M; Bastlund JF; Jensen AA
    Basic Clin Pharmacol Toxicol; 2015 Mar; 116(3):187-200. PubMed ID: 25441336
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 3-Furan-2-yl-N-p-tolyl-acrylamide, a highly selective positive allosteric modulator of α7 nicotinic receptors, produces anxiolytic-like activity in mice.
    Targowska-Duda KM; Budzynska B; Michalak A; Jozwiak K; Biala G; Arias HR
    J Psychopharmacol; 2019 May; 33(5):558-567. PubMed ID: 30644335
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The subtype-selective nicotinic acetylcholine receptor positive allosteric potentiator 2087101 differentially facilitates neurotransmission in the brain.
    de Filippi G; Mogg AJ; Phillips KG; Zwart R; Sher E; Chen Y
    Eur J Pharmacol; 2010 Sep; 643(2-3):218-24. PubMed ID: 20624387
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuropharmacological modulation of the P3-like event-related potential in a rat two-tone auditory discrimination task with modafinil and NS9283, a positive allosteric modulator of α4β2 nAChRs.
    Grupe M; Grunnet M; Laursen B; Bastlund JF
    Neuropharmacology; 2014 Apr; 79():444-55. PubMed ID: 24361451
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Procognitive effects of varenicline in the animal model of schizophrenia depend on α4β2- and α 7-nicotinic acetylcholine receptors.
    Potasiewicz A; Golebiowska J; Popik P; Nikiforuk A
    J Psychopharmacol; 2018 Dec; 33(1):269881118812097. PubMed ID: 30501536
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Positive allosteric modulation of alpha-7 nicotinic receptors promotes cell death by inducing Ca(2+) release from the endoplasmic reticulum.
    Guerra-Álvarez M; Moreno-Ortega AJ; Navarro E; Fernández-Morales JC; Egea J; López MG; Cano-Abad MF
    J Neurochem; 2015 May; 133(3):309-19. PubMed ID: 25650007
    [TBL] [Abstract][Full Text] [Related]  

  • 39. alpha4beta2 nicotinic receptors with high and low acetylcholine sensitivity: pharmacology, stoichiometry, and sensitivity to long-term exposure to nicotine.
    Moroni M; Zwart R; Sher E; Cassels BK; Bermudez I
    Mol Pharmacol; 2006 Aug; 70(2):755-68. PubMed ID: 16720757
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epibatidine induces long-term potentiation (LTP) via activation of alpha4beta2 nicotinic acetylcholine receptors (nAChRs) in vivo in the intact mouse dentate gyrus: both alpha7 and alpha4beta2 nAChRs essential to nicotinic LTP.
    Matsuyama S; Matsumoto A
    J Pharmacol Sci; 2003 Oct; 93(2):180-7. PubMed ID: 14578586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.